We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.13B
AUM Growth
+$358M
Cap. Flow
+$4.93M
Cap. Flow %
0.1%
Top 10 Hldgs %
21.38%
Holding
316
New
42
Increased
108
Reduced
79
Closed
41

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$28.9M
2
TWX
Time Warner Inc
TWX
+$28.6M
3
PRGO icon
Perrigo
PRGO
+$28.5M
4
RL icon
Ralph Lauren
RL
+$28.5M
5
LVNTA
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
+$28.1M

Top Sells

Rank Stock Value
1
IMO icon
Imperial Oil
IMO
+$40.7M
2
CELG
Celgene Corp
CELG
+$29.8M
3
V icon
Visa
V
+$28.3M
4
CMI icon
Cummins
CMI
+$26M
5
HSIC icon
Henry Schein
HSIC
+$25.4M

Sector Composition

Rank Sector Weight
1 Technology 25.64%
2 Financials 21.45%
3 Healthcare 20.19%
4 Communication Services 11.21%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALDR
226
DELISTED
Alder Biopharmaceuticals
ALDR
$745K 0.01%
+25,596
New +$459K
AERI
227
DELISTED
Aerie Pharmaceuticals
AERI
$742K 0.01%
25,407
+8,794
+53% +$223K
RLYP
228
DELISTED
RELYPSA INC COM
RLYP
$738K 0.01%
+23,969
New +$570K
BMRN icon
229
BioMarin Pharmaceuticals
BMRN
$12B
$712K 0.01%
7,875
+3,910
+99% +$325K
VIVO
230
DELISTED
Meridian Bioscience Inc
VIVO
$704K 0.01%
42,800
– –
CPHD
231
DELISTED
Cepheid Inc
CPHD
$704K 0.01%
13,006
+2,903
+29% +$147K
MDVN
232
DELISTED
MEDIVATION, INC.
MDVN
$689K 0.01%
+13,834
New +$719K
LAB icon
233
Standard BioTools
LAB
$308M
$681K 0.01%
20,194
+5,460
+37% +$155K
EIGR
234
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$680K 0.01%
+77
New +$447K
MCK icon
235
McKesson
MCK
$103B
$623K 0.01%
3,000
-106,603
-97% -$21.7M
ALNY icon
236
Alnylam Pharmaceuticals
ALNY
$38.4B
$618K 0.01%
6,370
-4,586
-42% -$425K
A icon
237
Agilent Technologies
A
$40B
$614K 0.01%
15,000
-5,970
-28% -$241K
MODN
238
DELISTED
MODEL N, INC.
MODN
$531K 0.01%
+50,000
New +$506K
VRTX icon
239
Vertex Pharmaceuticals
VRTX
$123B
$514K 0.01%
+4,329
New +$488K
SIVB
240
DELISTED
SVB Financial Group
SIVB
$502K 0.01%
4,326
-89
-2% -$9.71K
PCRX icon
241
Pacira BioSciences
PCRX
$1.06B
$451K 0.01%
+5,087
New +$481K
PRQR icon
242
ProQR Therapeutics
PRQR
$236M
$406K 0.01%
+18,754
New +$285K
PPBI
243
DELISTED
Pacific Premier Bancorp
PPBI
$399K 0.01%
+23,019
New +$364K
PB icon
244
Prosperity Bancshares
PB
$8.75B
$375K 0.01%
6,773
-1,364
-17% -$77.3K
ALKS icon
245
Alkermes
ALKS
$8.35B
$358K 0.01%
6,121
-1,502
-20% -$76.5K
OXFD
246
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$355K 0.01%
26,084
+12,403
+91% +$170K
CASH icon
247
Pathward Financial
CASH
$1.83B
$315K 0.01%
+26,994
New +$323K
SUPN icon
248
Supernus Pharmaceuticals
SUPN
$2.74B
$269K 0.01%
+32,428
New +$272K
AGEN
249
Agenus
AGEN
$250M
$251K ﹤0.01%
+3,227
New +$199K
AFMD
250
DELISTED
Affimed
AFMD
$229K ﹤0.01%
+3,696
New +$210K
8 9
10
11 12

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2014 Portfolio in Review

As of Q4 2014, Polar Capital held 316 positions worth $5.13B, up 7.5% from $4.77B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Polar Capital's Q4 2014 filing shows 42 new, 108 increased, 79 reduced and 41 closed positions. Its largest new stake was Accenture: 348,091 shares worth $31.1M. The largest sale was Imperial Oil, an estimated $40.7M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Polar Capital's largest Q4 2014 buy was Accenture: 348,091 shares worth $31.1M.
  • Polar Capital added most to Time Warner Inc in Q4 2014, an estimated $28.6M increase.
  • Polar Capital's biggest Q4 2014 reduction was Celgene Corp, cutting an estimated $29.8M.
  • Polar Capital fully exited Imperial Oil in Q4 2014, selling an estimated $40.7M.
  • Polar Capital's ten largest holdings make up 21% of its $5.13B portfolio in Q4 2014.
  • Polar Capital opened 42 new positions and closed 41 in Q4 2014.
  • Polar Capital's portfolio value rose 7.5% quarter-over-quarter to $5.13B.

Based on Polar Capital's 13F filing for Q4 2014, filed 17 Feb 2015.